program

Program Highlights

• Lectures and scientific abstracts on pathology, genetics, tumor microenvironment, therapeutics, clinical studies, quality of life and leading-edge research in cutaneous lymphomas
• Practice-changing workshops
• Debates and discussions on key controversies
• Interactive question and answer sessions
• Poster sessions
• Career and networking opportunities – discussions on research mentorship, industry relations and patient engagement

Credit © Helena Chu

Program at a glance

6th World Congress of Cutaneous Lymphomas Starting:

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

30000-Crédit FR © Tourisme Montréal, Stéphan Poulin-EN Credit © Tourisme Montréal, Stéphan Poulin

Credit © Tourism Montréal, Stéphan Poulin

35348-Crédit FR © Brandon Barré - 2017-EN Credit © Brandon Barré - 2017

Credit © Brandon Barré

48898-Credit FR © Château-Bromont-EN Credit © Château-Bromont

Credit © Chateau Bromont

37783-Credit FR © Fitz & Follwell Co.-EN Credit © Fitz & Follwell Co

Credit © Fitz & Folwell Co.

50324-Credit FR © Laurène Tinel - Tourisme Montréal -EN Credit © Laurène Tinel - Tourisme Montréal_

Credit © Laurene Tinel – Tourism Montréal

6th World Congress of Cutaneous Lymphomas

Call for Abstracts

The 6th World Congress of Cutaneous Lymphomas (6WCCL) will be held June 25–27, 2026, at the Westin Montréal in Montréal, Canada. This premier international meeting will showcase the latest advances in the research, diagnosis, and management of cutaneous lymphomas. The Scientific Committee invites you to submit abstracts for consideration as oral or poster presentations. Including opportunities for young investigators. Submissions from across the global community of experts are encouraged, with acceptance based on scientific merit. Join us in contributing to a dynamic program that will make this our most impactful Congress yet.

Abstract submissions will be accepted for the following topics:

  1. Classification / Epidemiology / Prognostic Factors
  2. Therapeutics / Preclinical Studies
  3. Pathology / Biomarkers / microenvironment
  4. Cutaneous Lymphoma International Consortium – PROCLIPI Studies
  5. Quality of Life / Patient Reported Outcomes
  6. Challenging Cases of Cutaneous Lymphomas

IMPORTANT DATES:

6WCCL Online Abstract System opens:

Abstract Submission Deadline:

Abstract Notification: 

Late-breaking Abstract System opens: 

Presenting Author Registration Deadline:

Late-breaking Abstract Deadline: 

Presentation at the 6WCCL: 

Thursday, October 16, 2025

Friday, January 23, 2026 – now closed

Thursday, February 26, 2026

Thursday, February 26, 2026

Tuesday, March 17, 2026

Monday, March 23, 2026

June 25-27, 2026

6th World Congress of Cutaneous Lymphomas

Workshops

            More information will be posted soon. Please check back for updates.

6th World Congress of Cutaneous Lymphomas

Invited Keynote Speakers

Thomas S. Kupper, MD
Chair Emeritus, Department of Dermatology, Brigham and Women’s Hospital
Chair, Department of Dermatology, Dana-Farber Cancer Institute
Thomas B. Fitzpatrick Professor, Harvard Medical School

Keynote Presentation: 40 Years of Research on Skin Immunity

Dr. Kupper was the founding Chair of the Department of Dermatology at Brigham and Women’s Hospital, where he led the department for more than 25 years.  He is chair at the Dana Farber Cancer Institute, and the Thomas B Fitzpatrick Professor of Dermatology at Harvard Medical School. He is the founder of the Cutaneous Oncology Disease Center and leads the Cutaneous Lymphoma Program at the Dana-Farber Cancer Center.  Dr. Kupper is an internationally known expert in the treatment and care of Cutaneous Lymphomas. He is also a respected teacher and mentor, and many of his trainees have gone on to become Department Chairs, Chiefs, or academic faculty around the country and the world.  Dr. Kupper’s research has been continuously funded by the National Institutes of Health for 35 years and is focused on: 1) T cell vaccine biology, 2) T cell immunobiology, including T cell subsets resident to tissue (TRM), and 3) Cancer immunobiology including immunotherapy. His current work is supported by the National Institutes for Allergy and Infectious Diseases, the National Institute for Arthritis, Musculoskeletal and Skin Diseases and the National Institute for Cancer. He has previously been funded by a MERIT award from the NIAID, the first Specialized Program in Research Excellence (SPORE) in Skin Cancer (NCI), and a Transformative Research Award from the NIH Office of the Director. He has served on multiple NIH study sections from 1991 to present.   He has received numerous awards, including the SID William Montagna Award and Kligman-Frost Leadership Award, the JSID Tanioku Kihei Award, the ESDR Rene Touraine Award, the AAD Marion Sulzberger Award, and is an honorary member of the Korean, Japanese, Swiss, and Austrian Societies for Investigative Dermatology. He has been elected to the American Society for Clinical Investigation, the American Dermatologic Association, the American Association of Physicians and is a Fellow of the American Association of Arts and Sciences.

 

Jason Hipp, MD, PhD
Chief Digital Innovation Officer for Mayo Collaborative Services
Medical Director for Biopharma Diagnostics

Keynote Presentation: Advances in Computational/Digital Pathology and AI in the diagnosis of Cancer and Prediction of Prognosis

 

6th World Congress of Cutaneous Lymphomas

 CME Accreditation

An accreditation application from the royal College of Physicians and Surgeons of Canada (Section 1 – Group Learning Activity) is currently in progress for the 6WCCL. Accreditation details, including the number of eligible hours, will be posted on the WCCL website once available.

6th World Congress of Cutaneous Lymphomas

Social Program (& Tours)

More information will be posted as it becomes available.

6th World Congress of Cutaneous Lymphomas Starting:

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

6th World Congress of Cutaneous Lymphomas

Contact Us!

For more information, please contact the Congress Secretariat, Simply Eventful Management